Allurion to sell 900,000 shares at $5.23 in registered direct offering

Allurion Technologies (ALUR) announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of 900,000 shares of the company’s common stock at a price of $5.23 per share in a registered direct offering. In addition, the company will issue to the investors warrants to purchase up to 1,800,000 shares of common stock in a concurrent private placement. The warrants have an exercise price of $5.23 per share and will become exercisable immediately following the date of stockholder approval and expire on the fifth anniversary of receipt of such approval. The registered direct offering of common stock and the concurrent private placement of warrants are collectively referred to as the offering herein. In addition, the company entered into a subscription agreement with funds affiliated with Leavitt Equity Partners for the purchase and sale of 267,686 shares of common stock and warrants to purchase up to 535,372 shares of common stock in a concurrent private placement at a purchase price of $5.23 per share and accompanying warrant. Roth Capital Partners is acting as the exclusive placement agent for the offering and the concurrent private placement.